← back to search

Jim C. Hu

NewYork–Presbyterian Hospital ·
Area of research
Pulmonary and Respiratory Medicine · Radiation
Research interest
Research interests include Prostate Cancer Diagnosis and Treatment, Prostate Cancer Treatment and Research, Advanced Radiotherapy Techniques, and Urinary Bladder and Prostate Research.
h-index
68
citations
20,268
works
593
NIH funding
primary concept
email

Recent publications

Biparametric vs Multiparametric MRI for Prostate Cancer Diagnosis
JAMA 2025cited by 40position: middledoi
Review of Transperineal and Transrectal Prostate Biopsy Outcomes
European Urology Focus 2025cited by 10position: lastdoi
Surgical Performance Metrics for 1-Year Patient-Reported Outcomes After Radical Prostatectomy
JAMA Surgery 2025cited by 6position: middledoi
Evaluating PI-RADS lesions and clinically significant prostate cancer in Black and Asian men: a PREVENT randomized clinical trial secondary analysis
Prostate Cancer and Prostatic Diseases 2025cited by 4position: middledoi
Transperineal Versus Transrectal Magnetic Resonance Imaging–targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREVENT Randomized Trial
European Urology 2024cited by 172position: firstdoi
Transperineal vs Transrectal Prostate Biopsy—The PREVENT Randomized Clinical Trial
JAMA Oncology 2024cited by 32position: firstdoi
Trends in Active Surveillance for Men With Intermediate-Risk Prostate Cancer
JAMA Network Open 2024cited by 17position: middledoi
Oncologic Outcomes of Testosterone Therapy for Men on Active Surveillance for Prostate Cancer: A Population-based Analysis
European Urology Open Science 2024cited by 11position: lastdoi
Impact of Magnetic Resonance Imaging Targeting on Pathologic Upgrading and Downgrading at Prostatectomy: A Systematic Review and Meta-analysis
European Urology Oncology 2023cited by 39position: middledoi
Use of the Decipher genomic classifier among men with prostate cancer in the United States
JNCI Cancer Spectrum 2023cited by 16position: middledoi
Targeted Prostate Biopsy: Umbra, Penumbra, and Value of Perilesional Sampling
European Urology 2022cited by 157position: middledoi
Role of Prophylactic Antibiotics in Transperineal Prostate Biopsy: A Systematic Review and Meta-analysis
European Urology Open Science 2022cited by 61position: middledoi
Surgical gestures as a method to quantify surgical performance and predict patient outcomes
npj Digital Medicine 2022cited by 54position: middledoi
Harm-to-Benefit of Three Decades of Prostate Cancer Screening in Black Men
NEJM Evidence 2022cited by 41position: middledoi
Grade Migration of Prostate Cancer in the United States During the Last Decade
JNCI Journal of the National Cancer Institute 2022cited by 39position: lastdoi
Advancing the Real-World Evidence for Medical Devices through Coordinated Registry Networks
BMJ Surgery Interventions & Health Technologies 2022cited by 24position: middledoi
An Assessment Tool to Provide Targeted Feedback to Robotic Surgical Trainees: Development and Validation of the End-to-End Assessment of Suturing Expertise (EASE)
Urology Practice 2022cited by 19position: middledoi
Findings from an international survey of urology trainee experience with prostate biopsy
British Journal of Urology 2022cited by 16position: middledoi
Magnetic Resonance Imaging Radiomics‐Based Machine Learning Prediction of Clinically Significant Prostate Cancer in Equivocal <scp>PI‐RADS</scp> 3 Lesions
Journal of Magnetic Resonance Imaging 2021cited by 57position: lastdoi
Increasing Utilization of MRI Before Prostate Biopsy in Black and Non-Black Men: An Analysis of the SEER-Medicare Cohort
American Journal of Roentgenology 2021cited by 43position: middledoi
Patient Satisfaction With Telemedicine During the COVID-19 Pandemic: Retrospective Cohort Study
Journal of Medical Internet Research 2020cited by 475position: lastdoi
Retzius-sparing Robot-assisted Radical Prostatectomy Leads to Durable Improvement in Urinary Function and Quality of Life Versus Standard Robot-assisted Radical Prostatectomy Without Compromise on Oncologic Efficacy: Single-surgeon Series and Step-by-step Guide
European Urology 2020cited by 101position: middledoi
Reconsidering the Trade-offs of Prostate Cancer Screening
New England Journal of Medicine 2020cited by 83position: lastdoi
Trends in the Use of Stereotactic Body Radiotherapy for Treatment of Prostate Cancer in the United States
JAMA Network Open 2020cited by 74position: middledoi
Concordance Between Biopsy and Radical Prostatectomy Pathology in the Era of Targeted Biopsy: A Systematic Review and Meta-analysis
European Urology Oncology 2019cited by 102position: lastdoi
A Population-based Study of Ureteroenteric Strictures After Open and Robot-assisted Radical Cystectomy
Urology 2019cited by 54position: lastdoi
Definitive and sustained increase in prostate cancer metastases in the United States
Urologic Oncology Seminars and Original Investigations 2019cited by 28position: lastdoi
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis
New England Journal of Medicine 2018cited by 2,964position: middledoi
Evaluation of the contribution of demographics, access to health care, treatment, and tumor characteristics to racial differences in survival of advanced prostate cancer
Prostate Cancer and Prostatic Diseases 2018cited by 84position: middledoi
Posterior, Anterior, and Periurethral Surgical Reconstruction of Urinary Continence Mechanisms in Robot-assisted Radical Prostatectomy: A Description and Video Compilation of Commonly Performed Surgical Techniques
European Urology 2018cited by 60position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Paul L. Nguyen · Harvard University18 papers (2012–2019)Quoc‐Dien Trinh · Brigham and Women's Hospital15 papers (2012–2018)Jonathan E. Shoag · NewYork–Presbyterian Hospital12 papers (2016–2024)Stuart R. Lipsitz · Hesco (United States)11 papers (2012–2018)Toni K. Choueiri · Harvard University9 papers (2012–2018)Keith Kowalczyk · Georgetown University9 papers (2012–2024)Nathanael D. Hevelone · University of Massachusetts Chan Medical School9 papers (2012–2017)Art Sedrakyan · Cornell University9 papers (2016–2021)Maxine Sun · Harvard University8 papers (2012–2018)Andrew J. Vickers · Nashville Oncology Associates6 papers (2017–2025)Joshua A. Halpern · Centennial Medical Center6 papers (2016–2017)Edward M. Schaeffer · Northwestern University6 papers (2017–2025)Christopher E. Barbieri · Cornell University5 papers (2016–2024)Daniel Margolis · Cornell University5 papers (2014–2021)Jason D. Wright · New York Oncology Hematology5 papers (2016–2016) · 5 papers (2012–2012)Pierre I. Karakiewicz · Université de Montréal5 papers (2012–2014)Himanshu Nagar · Memorial Sloan Kettering Cancer Center4 papers (2020–2024)Neil E. Martin · Pacific Heart Institute4 papers (2014–2015)Simon P. Kim · University of Colorado Denver4 papers (2013–2014)